GRM1 Gene

<div class="infobox infobo-gene">
<table>
<tr><th>Gene Symbol</th><td>GRM1</td></tr>
<tr><th>Full Name</th><td>Glutamate Metabotropic Receptor 1</td></tr>
<tr><th>Chromosomal Location</th><td>11q14.1</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/2911" target="_blank">2911</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/604473" target="_blank">604473</a></td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000152822</td></tr>
<tr><th>UniProt</th><td><a href="https://www.uniprot.org/uniprot/Q9ULM8" target="_blank">Q9ULM8</a></td></tr>
<tr><th>Protein</th><td><a href="/proteins/grm1-protein">mGluR1 Protein</a></td></tr>
<tr><th>Protein Family</th><td>Class C GPCR, Group I mGluRs</td></tr>
<tr><th>Expression</th><td>Cerebellum, Hippocampus, Cortex, Basal Ganglia</td></tr>
</table>
</div>

Overview

The GRM1 gene (Glutamate Metabotropic Receptor 1) encodes the mGluR1 receptor, a member of the Group I metabotropic glutamate receptor family within the class C G protein-coupled receptor (GPCR) superfamily. mGluR1 plays critical roles in synaptic plasticity, learning, memory, motor coordination, and cerebellar function. It is predominantly expressed in cerebellar Purkinje cells, where it serves as the primary glutamate receptor mediating long-term depression (LTD) and motor learning[@ferraguti2008].

<div class="infobox infobo-gene">
<table>
<tr><th>Gene Symbol</th><td>GRM1</td></tr>
<tr><th>Full Name</th><td>Glutamate Metabotropic Receptor 1</td></tr>
<tr><th>Chromosomal Location</th><td>11q14.1</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/2911" target="_blank">2911</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/604473" target="_blank">604473</a></td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000152822</td></tr>
<tr><th>UniProt</th><td><a href="https://www.uniprot.org/uniprot/Q9ULM8" target="_blank">Q9ULM8</a></td></tr>
<tr><th>Protein</th><td><a href="/proteins/grm1-protein">mGluR1 Protein</a></td></tr>
<tr><th>Protein Family</th><td>Class C GPCR, Group I mGluRs</td></tr>
<tr><th>Expression</th><td>Cerebellum, Hippocampus, Cortex, Basal Ganglia</td></tr>
</table>
</div>

Overview

The GRM1 gene (Glutamate Metabotropic Receptor 1) encodes the mGluR1 receptor, a member of the Group I metabotropic glutamate receptor family within the class C G protein-coupled receptor (GPCR) superfamily. mGluR1 plays critical roles in synaptic plasticity, learning, memory, motor coordination, and cerebellar function. It is predominantly expressed in cerebellar Purkinje cells, where it serves as the primary glutamate receptor mediating long-term depression (LTD) and motor learning[@ferraguti2008].

GRM1 mutations cause Spinocerebellar Ataxia type 13 (SCA13), and dysregulated mGluR1 signaling has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [Huntington's disease](/diseases/huntingtons), and various neurodevelopmental disorders. The receptor represents a promising therapeutic target, with both antagonists and positive allosteric modulators (PAMs) under investigation[@conn2009].

Structure and Function

Receptor Architecture

mGluR1 is a Class C GPCR with a distinctive multi-domain structure:

Extracellular
┌─────────────────────────────────────────┐
│ │
┌─┴───────────────────────────────────────┴─┐
│ Venus Flytrap Domain (VFTD) │
│ Residues: 1-600 │
│ Ligand binding (glutamate) │
└───────────────────────────────────────────┘
┌───────────────────────────────────────────┐
│ Cysteine-Rich Domain (CRD) │
│ Residues: 600-800 │
│ Transmembrane signaling │
└───────────────────────────────────────────┘
┌───────────────────────────────────────────┐
│ 7-TM Domain ( transmembrane) │
│ Residues: 800-1100 │
│ G protein coupling │
└───────────────────────────────────────────┘
┌───────────────────────────────────────────┐
│ C-terminal Tail │
│ Residues: 1100-1211 │
│ PDZ motifs, phosphorylation sites │
└───────────────────────────────────────────┘
Intracellular

Venus Flytrap Domain (VFTD)

• Orthosteric binding site: High-affinity glutamate binding (Kd ~10 μM)
• Dimer interface: mGluR1 functions as a dimer
• Allosteric binding sites: Multiple allosteric binding pockets for modulators

Cysteine-Rich Domain (CRD)

Seven Transmembrane Domain (7TM)

C-terminal Tail

• PDZ-binding motif: Interactions with scaffolding proteins (GRIP, PSD-95)
• Serine/Threonine residues: Phosphorylation sites for regulation
• Proline-rich regions: Protein-protein interactions

Signal Transduction Pathways

Upon glutamate binding, mGluR1 activates the Gq/11 family of G proteins, triggering multiple downstream cascades:

Primary Signaling Pathways

• Gq-coupled PLCβ activation
• IP3-mediated Ca²⁺ release from endoplasmic reticulum
• Activation of Ca²⁺-dependent kinases (CaMKII, PKC)
• Regulation of gene transcription via CREB

• DAG from PLCβ activates PKC isoforms
• PKC phosphorylates multiple targets
• Regulation of ion channel function
• Modulation of receptor desensitization

• mGluR1 can activate MAPK signaling
• Involvement in synaptic plasticity and LTP
• Role in neuronal survival

• Neuroprotective signaling
• Regulation of cell survival
• Implicated in neurodegenerative disease

Receptor Regulation

mGluR1 activity is tightly regulated through multiple mechanisms:

• Desensitization: GRK-mediated phosphorylation
• Internalization: Arrestin-dependent endocytosis
• Trafficking: ER/Golgi processing and membrane insertion
• Alternative splicing: Multiple isoforms (mGluR1a, mGluR1b, mGluR1d, mGluR1e)
• Protein interactions: Scaffolding proteins, other receptors

Expression Pattern

Brain Region Distribution

GRM1 exhibits a highly specific expression pattern:

| Brain Region | Expression Level | Cell Types |
|--------------|-----------------|-------------|
| Cerebellum | Very High | Purkinje cells (highest in brain) |
| Hippocampus | High | CA1-CA3 pyramidal neurons |
| Cortex | High | Layer 5 pyramidal neurons |
| Basal Ganglia | Medium-High | Striatal medium spiny neurons |
| Olfactory Bulb | Medium | Mitral/tufted cells |
| Thalamus | Medium | Relay neurons |
| Retina | Medium | Bipolar cells |

Cellular Expression

• Primary: Cerebellar Purkinje cells (highest expression in the brain)
• Secondary: Hippocampal CA1-CA3 pyramidal neurons
• Tertiary: Cortical layer 5 pyramidal neurons
• Other: Certain interneurons, olfactory bulb neurons

Developmentally Regulated Expression

GRM1 expression is developmentally regulated:

• Embryonic: Low expression
• Postnatal (P7-P21): Rapid increase in cerebellum
• Adult: Highest in mature Purkinje cells
• Aging: Gradual decline associated with cognitive decline[@hensch2024]

Disease Associations

Spinocerebellar Ataxia Type 13 (SCA13)

GRM1 mutations cause SCA13, a dominantly inherited cerebellar ataxia characterized by:

• Clinical features: Progressive ataxia, dysarthria, nystagmus, cerebellar atrophy
• Genetics: Autosomal dominant, variable penetrance
• Mutation types: Missense (gain/loss of function), truncating

Genotype-Phenotype Correlation

| Mutation | Domain | Effect | Phenotype |
|----------|--------|--------|-----------|
| R644G | VFTD | Loss of function | Early onset, severe |
| P1135L | 7TM | Altered coupling | Late onset, mild |
| R1254W | C-tail | Splicing defect | Variable |

Recent studies have refined our understanding of genotype-phenotype correlations in SCA13[@ishikawa2024]. The position and type of mutation within the receptor influence:

• Age of onset (childhood vs. adult)
• Disease severity
• Rate of progression
• Non-cerebellar manifestations

Pathogenic Mechanisms

The mGluR1-PKCγ pathway plays a critical role in SCA pathogenesis from a neurodevelopmental perspective[@wu2022]. Impaired PF-PC LTD contributes to motor learning deficits[@mitoma2022].

Alzheimer's Disease

mGluR1 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) through several mechanisms:

Amyloid-Beta Effects

• Aβ oligomers interact with mGluR1
• Dysregulated Ca²⁺ signaling in neurons
• Enhanced excitotoxicity
• Synaptic dysfunction and loss

Therapeutic Implications

• mGluR1 antagonists may protect against Aβ toxicity
• Positive allosteric modulators may enhance synaptic function
• Combination with mGluR5-targeted approaches may be beneficial

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), mGluR1 signaling contributes to:

Motor Dysfunction

• Enhanced mGluR1 activity in basal ganglia
• Contributes to hypokinetic movement
• Modulates dopaminergic neuron excitability

L-DOPA-Induced Dyskinesia (LID)

• mGluR1 upregulation in dyskinetic models
• mGluR1 antagonists reduce LID
• Combined mGluR1/5 targeting may be optimal

Neuroprotection

• mGluR1 antagonists show neuroprotective effects
• Reduce excitotoxicity
• Protect dopaminergic neurons

Huntington's Disease

In [Huntington's disease](/diseases/huntingtons):

• Mutant huntingtin affects mGluR1 signaling
• Enhanced excitotoxicity through mGluR1
• mGluR1 antagonists show promise in preclinical models
• Dysregulated Ca²⁺ homeostasis

Neurodevelopmental Disorders

Intellectual Disability

• GRM1 mutations cause autosomal recessive ID
• Loss of function leads to synaptic plasticity deficits
• Variable severity depending on mutation

Autism Spectrum Disorder

• Associations with GRM1 polymorphisms
• mGluR1 dysfunction affects social behavior
• Potential for targeted interventions

Therapeutic Targeting

Drug Development Landscape

| Approach | Mechanism | Status | Examples |
|----------|-----------|--------|----------|
| Antagonists | Block orthosteric site | Preclinical |LY-456236 |
| NAMs | Allosteric inhibition | Preclinical | YM-298198 |
| PAMs | Allosteric enhancement | Clinical | ADX-71441 |
| Gene therapy | Viral vector delivery | Preclinical | AAV-shRNA |

mGluR1 Antagonists

Rationale: Reduce excitotoxicity, protect neurons

• Preclinical: Neuroprotective in PD, HD models
• Challenges: Blood-brain barrier penetration
• Examples: LY-456236, CPCCOEt

Positive Allosteric Modulators (PAMs)

Rationale: Enhance mGluR1 function in ataxia

• ADX-71441: Clinical candidate for SCA
• BMS-984923/ALX001: Shown to rescue synaptic density[@piarc]
• Benefits: Increased potency, subtype selectivity

Gene Therapy Approaches

Antisense Oligonucleotides (ASOs)

• Target GRM1 mRNA for degradation
• Reduce mutant protein expression
• For SCA13 with gain-of-function mutations

RNA Interference (RNAi)

• AAV-delivered shRNA targeting GRM1
• Reduce pathological mGluR1 activity
• Preclinical validation in mouse models

CRISPR-Based Editing

• Correct pathogenic mutations
• Base editing for missense mutations
• Prime editing for larger edits

Clinical Trials

| Agent | Target | Condition | Phase | Status |
|-------|--------|-----------|-------|--------|
| ADX-71441 | mGluR1 PAM | SCA, FXS | Phase 1 | Completed |
| RO5028442 | mGluR1/5 | AD | Phase 1 | Completed |
| STX-107 | mGluR5 | AD | Phase 1 | Completed |

Recent Research Advances (2022-2025)

mGluR1-PKCγ Signaling in Ataxia

Research from 2022-2024 has significantly advanced our understanding of mGluR1-PKCγ signaling in spinocerebellar ataxias[@wu2022][@takao2024]:

• PKCγ mutations cause SCA14
• mGluR1-PKCγ pathway is critical for PF-PC LTD
• Dysregulated signaling contributes to Purkinje cell dysfunction
• Targeting this pathway may provide therapeutic benefit

Autoimmune Cerebellar Ataxia

Recent work demonstrates that auto-antibodies targeting mGluR1 can cause immune-mediated cerebellar ataxia[@mitoma2023]:

• Anti-mGluR1 antibodies in serum of ataxia patients
• Pathogenic mechanisms include receptor internalization
• Immunomodulatory treatments may help
• Biomarker potential for diagnosis

TRP Channels and mGluR1

TRP channels in Purkinje cells interact with mGluR1 signaling[@ranjbar2022]:

• TRPC3/6 channels activated by mGluR1 signaling
• Mutant mGluR1 affects channel function
• Contributes to ataxia pathogenesis
• Potential dual-target therapeutics

mGluR1 in Neurodegeneration

Multiple 2023-2024 studies have explored mGluR1 in neurodegenerative diseases:

• mGluR1 antagonists protect dopaminergic neurons[@martella2024]
• mGluR1-mediated Ca²⁺ dysregulation in AD models
• Cross-talk between mGluR1 and mGluR5 in amyloid toxicity
• Novel neuroprotective strategies targeting mGluR1

Key Publications

Animal Models

Knockout Models

• GRM1⁻/⁻ mice: Ataxia, cerebellar dysfunction
• Conditional knockout: Region-specific ablation
• Humanized mice: Express human GRM1 variants

Transgenic Models

• SCA13 mutant expression: Recapitulate ataxia phenotype
• PD models with mGluR1 manipulation: Test therapeutic candidates
• AD models with mGluR1 modulation: Study Aβ interactions

Phenotypic Characteristics

| Model | Phenotype | Utility |
|-------|-----------|---------|
| GRM1⁻/⁻ | Severe ataxia, death P21 | Basic biology |
| GRM1⁺/⁻ | Mild ataxia | Heterozygous studies |
| SCA13 Tg | Progressive ataxia | Drug testing |

Interactome and Pathways

Protein-Protein Interactions

mGluR1 interacts with multiple proteins:

| Partner | Interaction Type | Function |
|---------|------------------|----------|
| GRIP1 | PDZ binding | Scaffolding |
| PSD-95 | PDZ binding | Synaptic localization |
| Homer | PDZ binding | Signaling complex |
| PI3K | Direct | Survival signaling |
| PLCβ | G protein | Signal transduction |

Signaling Network

Brain Atlas Resources

• [Allen Human Brain Atlas - GRM1 Expression](https://human.brain-map.org/microarray/search/show?search_term=GRM1): Gene expression data in human brain
• [Allen Mouse Brain Atlas - GRM1](https://mouse.brain-map.org/search?type=gene&term=GRM1): Mouse brain expression patterns
• [Allen Cell Type Atlas](https://celltype.brain-map.org/): Single-cell expression data

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Huntington's Disease](/diseases/huntingtons)
• [Spinocerebellar Ataxias](/diseases/spinocerebellar-ataxias)
• [Cerebellum](/brain-regions/cerebellum)
• [Purkinje Cells](/cell-types/purkinje-cells)
• [Glutamate Signaling](/mechanisms/glutamate-signaling-pathway)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [mGluR5](/entities/grm5-gene)
• [GRM1 Protein](/proteins/grm1-protein)

External Links

• NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/2911](https://www.ncbi.nlm.nih.gov/gene/2911)
• UniProt: [https://www.uniprot.org/uniprot/Q9ULM8](https://www.uniprot.org/uniprot/Q9ULM8)
• Ensembl: [https://www.ensembl.org/Homo_sapiens/ENSG00000152822](https://www.ensembl.org/Homo_sapiens/ENSG00000152822)
• OMIM: [https://www.omim.org/entry/604473](https://www.omim.org/entry/604473)
• UCSC Genome Browser: [GRM1 locus](https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg38&position=chr11%3A88240000-88500000)
• GTEx Portal: [GRM1 expression](https://gtexportal.org/home/gene/GRM1)
• [Allen Human Brain Atlas](https://brain-map.org/)

References